Publicaciones científicas en Inglés. 2012

Tamargo J , Caballero R , Delpón E
Drug-induced atrial fibrillation: Does it matter?
Discov Med. 2012 Nov;14(78):295-9

Tamargo J.
TGFß3 mutations cause arrhythmogenic right ventricular dysplasia type 1 and open the door to understanding the biological role of TGFß3 (where there's a will, there's a way)
Cardiovasc Res. 2012 Nov 1;96(2):188-90
doi: 10.1093/cvr/cvs231

Tamargo J, Caballero R, Delpón E.
Drug-induced atrial fibrillation.
Expert Opin Drug Saf. 2012;11:615-34.

Quintela AM, Jiménez R, Gómez-Guzmán M, José Zarzuelo M, Galindo P, Sánchez M, Vargas F, Cogolludo A, Tamargo J, Pérez-Vizcaíno F, Duarte J.
Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR β/δ) prevents endothelial dysfunction in type 1 diabetic rats.
Free Radic Biol Med. 2012; 53:730-41

Tamargo J, Capucci A, Mabo P.
Safety of flecainide.
Drug Saf. 2012;35(4):273-89.

López-Farré AJ, Zamorano-León JJ, Segura A, Mateos-Cáceres PJ, Modrego J, Rodríguez-Sierra P, Calatrava L, Tamargo J, Macaya C.
Plasma Desmoplakin I Biomarker Of Vascular Recurrence After Ischemic Stroke.
J Neurochem. 2012; 121(2):314-25.

Gómez-Guzmán M, Jiménez R, Sánchez M, Zarzuelo MJ, Galindo P, Quintela AM, López-Sepúlveda R, romero M, Tamargo J, Vargas F, Pérez-Vizcaíno F, Duarte J.
Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NDPH oxidase actividy in DOCA-salt hypertension.
Free Radic Biol Med. 2012;52(1):70-9.

Galindo P, Rodriguez-Gómez I, González-Manzano S, Dueñas M, Jiménez R, Menéndez C, Vargas F, Tamargo J, Santos-Buelga C, Pérez-Vizcaíno F, Duarte J.
Glucuronidated Quercetin Lowers Blood Pressure in Spontaneously Hypertensive Rats via Deconjugation.
PLoS One. 2012;7(3):e32673.